SNWCX | VISVX | SNWCX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 3.488 | 3.197 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 28.7M | 58.3B | 0% |
Annual Yield % from dividends | 0.00 | 1.90 | - |
Returns for 1 year | 18.86 | 18.46 | 102% |
Returns for 3 years | 23.79 | 16.97 | 140% |
Returns for 5 years | 87.31 | 50.22 | 174% |
Returns for 10 years | 95.63 | 109.01 | 88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFGCX | 13.03 | 0.08 | +0.62% |
NAA World Equity Income C | |||
PAITX | 19.83 | 0.07 | +0.35% |
T. Rowe Price International Stock Adv | |||
WIAEX | 44.23 | 0.11 | +0.25% |
Wasatch Small Cap Growth Institutional | |||
ICEUX | 37.97 | 0.02 | +0.05% |
NYLI Epoch International Choice Class I | |||
FBDIX | 118.54 | -0.14 | -0.12% |
Franklin Biotechnology Discovery A |